Soluble endoglin and preeclampsia and intra-uterine growth retardation

Combined use of uterine artery Doppler velocimetry and placental growth factor, soluble vascular endothelial growth factor receptor-1 for identification of patients at risk for early onset and/or sever preeclampsia

First trimester assessment of placental functions and the prediction of preeclampsia and intrauterine growth restriction

Serum endoglin as a second trimester marker for predicting preeclampsia

Prediction of preeclampsia by the combined use of early second trimester maternal serum Histidine-Rich glycoprotein and uterine artery Doppler velocimetry

Serum C-reactive protein in women with preeclampsia

Maternal serum C-reactive protein as an indicator of severity of preeclampsia

Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in pre-eclampsia

First trimester screening for early predication of preeclampsia using combined serum placental protein 13 (PP13) and uterine arteries Doppler ultrasound

Endothelial microparticles and its relation to Doppler studies, in cases of pre-eclampsia